日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

作者更正:黏膜疫苗诱导的交叉反应性 CD8(+) T 细胞可预防 SARS-CoV-2 XBB.1.5 呼吸道感染

Ying, Baoling; Darling, Tamarand L; Desai, Pritesh; Liang, Chieh-Yu; Dmitriev, Igor P; Soudani, Nadia; Bricker, Traci; Kashentseva, Elena A; Harastani, Houda; Raju, Saravanan; Liu, Meizi; Schmidt, Aaron G; Curiel, David T; Boon, Adrianus C M; Diamond, Michael S

Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.

粘膜疫苗诱导的交叉反应性 CD8(+) T 细胞可预防 SARS-CoV-2 XBB.1.5 呼吸道感染

Ying Baoling, Darling Tamarand L, Desai Pritesh, Liang Chieh-Yu, Dmitriev Igor P, Soudani Nadia, Bricker Traci, Kashentseva Elena A, Harastani Houda, Raju Saravanan, Liu Meizi, Schmidt Aaron G, Curiel David T, Boon Adrianus C M, Diamond Michael S

Mineralo-organic particles inhibit influenza A virus infection by targeting viral hemagglutinin activity

矿物有机颗粒通过靶向病毒血凝素活性来抑制甲型流感病毒感染。

Chiang, Huan-Jung; Peng, Hsin-Hsin; Weng, Kuo-Feng; Hsiung, Kuei-Ching; Liang, Chieh-Yu; Kuo, Shun-Li; Ojcius, David M; Young, John Ding-E; Shih, Shin-Ru

A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters.

二价 ChAd 鼻腔疫苗可保护小鼠和仓鼠免受 SARS-CoV-2 BQ.1.1 和 XBB.1.5 感染和疾病的侵害

Ying Baoling, Darling Tamarand L, Desai Pritesh, Liang Chieh-Yu, Dmitriev Igor P, Soudani Nadia, Bricker Traci, Kashentseva Elena A, Harastani Houda, Schmidt Aaron G, Curiel David T, Boon Adrianus C M, Diamond Michael S

Robust induction of T(RM)s by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses

组合纳米壳对T(RM)的强效诱导赋予了针对致命性流感病毒的交叉毒株灭菌免疫力

Lin, Pin-Hung; Liang, Chieh-Yu; Yao, Bing-Yu; Chen, Hui-Wen; Pan, Ching-Fu; Wu, Li-Ling; Lin, Yi-Hsuan; Hsu, Yu-Sung; Liu, Yu-Han; Chen, Pei-Jer; Hu, Che-Ming Jack; Yang, Hung-Chih